Towa Pharmaceutical Co., Ltd. (4553.T)
Tokyo · JPY · Healthcare · Drug Manufacturers - Specialty & Generic
¥3,550 (+0.00%) as of
Key statistics
- Market cap
- 174.76B
- P/E (TTM)
- 21.14
- Forward P/E
- 12.04
- EPS (TTM)
- 167.94
- Dividend yield
- 2.25%
- 52-week range
- 2,764.00 – 4,490.00
- Beta
- -0.04
- Revenue (TTM)
- 279.94B
- Profit margin
- 2.95%
- Analyst target
- ¥5,350
- Volume
- 166.40k
About Towa Pharmaceutical Co., Ltd.
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT service related to healthcare; disease risk testing services; and sale of quasi drugs. In addition, it is involved in research and development and production of active pharmaceutical ingredients, intermediates, and support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Kadoma, Japan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Kadoma, Japan
- Employees
- 4,923
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.